ID   KE-24
AC   CVCL_W476
SY   KE24
DR   Wikidata; Q54899713
RX   PubMed=1958633;
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 32.4 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=15016319; DOI=10.1111/j.1349-7006.2004.tb02205.x; PMCID=PMC11159061;
RA   Yamashita, Kazuya
RA   Yasuda, Shuichi
RA   Kuba, Tatsuru
RA   Otani, Yoshimasa
RA   Fujiwara, Mutsunori
RA   Okayasu, Isao
RT   "Unique characteristics of rectal carcinoma cell lines derived from
RT   invasive carcinomas in ulcerative colitis patients.";
RL   Cancer Sci. 95:211-217(2004).
//
RX   PubMed=1958633;
RA   Yamashita, Kazuya
RA   Atari, Eio
RA   Watanabe, Kazue
RA   Shinoda, Hiroshi
RA   Yokozawa, Masashi
RT   "Establishment and characterization of strain KE-24 derived from human
RT   colonic cancer.";
RL   Hum. Cell 4:145-149(1991).
//